Severe autoinimune hepatitis in patients with previous spontaneous recovery of a flare

被引:15
作者
Dufour, JF [1 ]
Zimmermann, M [1 ]
Reichen, J [1 ]
机构
[1] Univ Bern, Dept Clin Pharmacol, CH-3010 Bern, Switzerland
关键词
autoimmune hepatitis; flares; alanine transaminase;
D O I
10.1016/S0168-8278(02)00329-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Autoimmune hepatitis can present acutely and pursues a variable, usually progressive course. Spontaneous remissions have been described, but their influence on the course of subsequent attacks has not yet been studied. Methods: Charts from 1980 to 2000 were reviewed. Cases of autoimmune hepatitis were further examined to identify those with prior episodes of transient elevation of the serum aminotransferase activities of unknown etiology. Results: Fifty-one patients with autoimmune hepatitis were identified, nine of whom (18%) had experienced a transient episode of elevated aminotransferase activities which had resolved spontaneously. The median period of time separating the two flares was 10 months (range: 4 months-23 years). The median age at diagnosis was 41 years in both groups. More than 75% of the patients in either group suffered from a type I autoimmune hepatitis. Importantly, patients with spontaneous recovery of a previous episode had a higher serum alanine transaminase activity (P < 0.02), were less likely to respond to immunosuppressive therapy (78 versus 98%, P = 0.077) and required transplantation more frequently (22 versus 0%, P = 0.028). Histologically, these patients did not have more fibrosis than patients without previous flare. Conclusions: More than 10% of autoimmune hepatitis may begin with a spontaneously resolving episode. However, the spontaneous recovery of a previous attack should not falsely reassure: a subsequent flare of autoimmune hepatitis can still be severe. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:748 / 752
页数:5
相关论文
共 31 条
[1]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[2]   Liver transplantation for autoimmune hepatitis: A long-term pathologic study [J].
Ayata, G ;
Gordon, FD ;
Lewis, WD ;
Pomfret, E ;
Pomposelli, JJ ;
Jenkins, RL ;
Khettry, U .
HEPATOLOGY, 2000, 32 (02) :185-192
[3]   CHRONIC HEPATITIS - AN UPDATE ON TERMINOLOGY AND REPORTING [J].
BATTS, KP ;
LUDWIG, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (12) :1409-1417
[4]   Remission of autoimmune hepatitis during pregnancy: a report of two cases [J].
Colle, I ;
Hautekeete, M .
LIVER, 1999, 19 (01) :55-57
[5]   CONTROLLED PROSPECTIVE TRIAL OF CORTICOSTEROID THERAPY IN ACTIVE CHRONIC HEPATITIS [J].
COOK, GC ;
MULLIGAN, R ;
SHERLOCK, S .
QUARTERLY JOURNAL OF MEDICINE, 1971, 40 (158) :159-+
[6]   SUSCEPTIBILITY TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS - HUMAN-LEUKOCYTE ANTIGENS-DR4 AND ANTIGEN-A1-B8-DR3 ARE INDEPENDENT RISK-FACTORS [J].
DONALDSON, PT ;
DOHERTY, DG ;
HAYLLAR, KM ;
MCFARLANE, IG ;
JOHNSON, PJ ;
WILLIAMS, R .
HEPATOLOGY, 1991, 13 (04) :701-706
[7]   Reversibility of hepatic fibrosis in autoimmune hepatitis [J].
Dufour, JF ;
DeLellis, R ;
Kaplan, MM .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (11) :981-985
[8]   THE NATURE OF UNEXPLAINED CHRONIC AMINOTRANSFERASE ELEVATIONS OF A MILD TO MODERATE DEGREE IN ASYMPTOMATIC PATIENTS [J].
HAY, JE ;
CZAJA, AJ ;
RAKELA, J ;
LUDWIG, J .
HEPATOLOGY, 1989, 9 (02) :193-197
[9]   Current and novel immunosuppressive therapy for autoimmune hepatitis [J].
Heneghan, MA ;
McFarlane, IG .
HEPATOLOGY, 2002, 35 (01) :7-13
[10]   Management and outcome of pregnancy in autoimmune hepatitis [J].
Heneghan, MA ;
Norris, SM ;
O'Grady, JG ;
Harrison, PM ;
McFarlane, IG .
GUT, 2001, 48 (01) :97-102